6-deoxy-6-bromoascorbic acid: RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 54711451 |
| SCHEMBL ID | 13238922 |
| MeSH ID | M0187485 |
| Synonym |
|---|
| 6-deoxy-6-bromoascorbic acid |
| 62983-44-2 |
| 6-bromo-6-deoxy-ascorbic acid |
| l-ascorbic acid, 6-bromo-6-deoxy- |
| 6-bromo-6-deoxy-l-ascorbic acid |
| SCHEMBL13238922 |
| 6-bromo-6-deoxyhex-1-enofuranos-3-ulose |
| DTXSID40978870 |
| (5r)-5-[(1r)-2-bromo-1-hydroxyethyl]-3,4-dihydroxy-2,5-dihydrofuran-2-one |
| (2r)-2-[(1r)-2-bromo-1-hydroxyethyl]-3,4-dihydroxy-2h-furan-5-one |
| EN300-314020 |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (57.14) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.23) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 7 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||